1. An Oral Formulation of the Probiotic, Bacillus subtilis HU58, Was Safe and Well Tolerated in a Pilot Study of Patients with Hepatic Encephalopathy. (30th June 2020) Authors: Yossef, Sayed; Clark, Frances; Bubeck, Sarah S.; Abernethy, John; Bayne, Thomas; Krishnan, Kiran; Young, Aicacia Other Names: Bastos Jairo Kenupp Academic Editor. Journal: Evidence-based complementary and alternative medicine Issue: Volume 2020(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Innovative Randomized Phase I Study and Dosing Regimen Selection to Accelerate and Inform Pivotal COVID‐19 Trial of Nirmatrelvir. Issue 1 (4th May 2022) Authors: Singh, Ravi Shankar P.; Toussi, Sima S.; Hackman, Frances; Chan, Phylinda L.; Rao, Rohit; Allen, Richard; Van Eyck, Lien; Pawlak, Sylvester; Kadar, Eugene P.; Clark, Frances; Shi, Haihong; Anderson, Annaliesa S.; Binks, Michael; Menon, Sandeep; Nucci, Gianluca; Bergman, Arthur Journal: Clinical pharmacology & therapeutics Issue: Volume 112:Issue 1(2022) Page Start: 101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗